Inicio/Acciones/TARS

TARS

USD

Tarsus Pharmaceuticals Inc. Common Stock

$68.250+0.440 (0.649%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$67.810

Máximo

$69.250

Mínimo

$65.935

Volumen

0.95M

Fundamentos de la Empresa

Capitalización de Mercado

2.9B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.65M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $38.51Actual $68.250Máximo $76.81

Noticias Relacionadas

4 nov 2025 · 21:05

GlobeNewswire

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring strong commercial

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

28 oct 2025 · 21:00

GlobeNewswire

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, 2025 to report its